Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

EMA endorses Novo Nordisk's Wegovy for treating heart failure and lowering heart risks in obese patients. Second approval ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Novo Nordisk receives a positive opinion from the CHMP for a label update of Wegovy to reflect reduced heart failure symptoms ...

The new entity, operational under the name MogulBodyCare, LLC, brings together the current offerings of both organizations and enables greater access to weight loss medications, i ...

The medtech industry hopes to capitalise on increased awareness about the obesity space to promote multidisciplinary ...

The drug, also known by brand names like Wegovy and Mounjaro, consists of semaglutide and tirzepatide. It is prescribed by doctors to transform how the brain addresses appetite and satiation. “Shouldn ...

Italy: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety ...